Samantha Miller
Chief Executive Officer at Cadence Health, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Carlos A. Schuler | M | - |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | 22 years |
| Keith Try Ung | M | - |
ipharma Labs, Inc.
 ipharma Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Meridian Medical Technologies LLC, ipharma Labs, Inc. operates as an inhalation development contract research organization. The company is based in Union City, CA. The company was founded in 2016 by Mei-Chang Kuo, Keith Try Ung, John Patton. Keith Try Ung has been the CEO since 2016. ipharma Labs was acquired by Kindeva Drug Delivery LP, part of Meridian Medical Technologies LLC from December 12, 2022 on June 16, 2022. | 8 years |
| Mei-Chang Kuo | M | 75 |
ipharma Labs, Inc.
ipharma Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Meridian Medical Technologies LLC, ipharma Labs, Inc. operates as an inhalation development contract research organization. The company is based in Union City, CA. The company was founded in 2016 by Mei-Chang Kuo, Keith Try Ung, John Patton. Keith Try Ung has been the CEO since 2016. ipharma Labs was acquired by Kindeva Drug Delivery LP, part of Meridian Medical Technologies LLC from December 12, 2022 on June 16, 2022. | 8 years |
| Roy Whitfield | M | 70 | 24 years | |
| John Patton | M | - |
ipharma Labs, Inc.
ipharma Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Meridian Medical Technologies LLC, ipharma Labs, Inc. operates as an inhalation development contract research organization. The company is based in Union City, CA. The company was founded in 2016 by Mei-Chang Kuo, Keith Try Ung, John Patton. Keith Try Ung has been the CEO since 2016. ipharma Labs was acquired by Kindeva Drug Delivery LP, part of Meridian Medical Technologies LLC from December 12, 2022 on June 16, 2022. | 8 years |
| Nathalie Molina Niño | F | - |
Cadence Health, Inc.
 Cadence Health, Inc. Medical/Nursing ServicesHealth Services Cadence Health, Inc. provides healthcare services. The company is headquartered in Houston, TX. | - |
| Molina Niño Nathalie | F | - |
Cadence Health, Inc.
Cadence Health, Inc. Medical/Nursing ServicesHealth Services Cadence Health, Inc. provides healthcare services. The company is headquartered in Houston, TX. | 5 years |
| Robert Bacci | M | - | 23 years | |
| Chet Leach | M | - |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | - |
| D Malcolm Potts | M | - |
Cadence Health, Inc.
Cadence Health, Inc. Medical/Nursing ServicesHealth Services Cadence Health, Inc. provides healthcare services. The company is headquartered in Houston, TX. | - |
| Robert Anthony Hosang | M | - |
Cadence Health, Inc.
Cadence Health, Inc. Medical/Nursing ServicesHealth Services Cadence Health, Inc. provides healthcare services. The company is headquartered in Houston, TX. | - |
| Richard Mark | M | 70 |
Cadence Health, Inc.
Cadence Health, Inc. Medical/Nursing ServicesHealth Services Cadence Health, Inc. provides healthcare services. The company is headquartered in Houston, TX. | - |
| Alan Colowick | M | 61 |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | 6 years |
| Andrew ElBardissi | M | 42 |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | - |
| George Bickerstaff | M | 68 |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | 4 years |
| Chris Collins | M | - |
NorthStar Solutions Group LLC
 NorthStar Solutions Group LLC Miscellaneous Commercial ServicesCommercial Services NorthStar Solutions Group LLC provides management consulting services. It operates through the following solution areas: Project and Program Management Execution, Business Intelligence, Customer Experience, and Cyber Security Solutions. The firm provides commercial businesses and government institutions with staff augmentation, business and systems integration, tool and product development, and consulting support services. The company was founded in 2004 and is headquartered in Reading, PA. | - |
| Isaac Cheng | M | 49 |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | - |
| Luiz Belardinelli | M | - |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | 8 years |
| Abigail Disney | M | - |
Cadence Health, Inc.
Cadence Health, Inc. Medical/Nursing ServicesHealth Services Cadence Health, Inc. provides healthcare services. The company is headquartered in Houston, TX. | - |
| Johan Rutger Christenson | M | 65 |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | - |
| Daniel Welch | M | 66 |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | 5 years |
| Louis Lange | M | 72 |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | - |
| Timothy Koogle | M | 72 |
Cadence Health, Inc.
Cadence Health, Inc. Medical/Nursing ServicesHealth Services Cadence Health, Inc. provides healthcare services. The company is headquartered in Houston, TX. | - |
| John Pritchard | M | - |
ipharma Labs, Inc.
ipharma Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Meridian Medical Technologies LLC, ipharma Labs, Inc. operates as an inhalation development contract research organization. The company is based in Union City, CA. The company was founded in 2016 by Mei-Chang Kuo, Keith Try Ung, John Patton. Keith Try Ung has been the CEO since 2016. ipharma Labs was acquired by Kindeva Drug Delivery LP, part of Meridian Medical Technologies LLC from December 12, 2022 on June 16, 2022. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christopher Kuebler | M | 70 | 17 years | |
| Truc Le | M | 71 | 6 years | |
| Juergen A. Martens | M | 68 | 5 years | |
| Stephen Hurst | M | - | 8 years | |
| Ed Mathers Mathers | M | 64 | 2 years | |
| Joseph F. Bohan | M | 66 | 5 years | |
| Surendra Patel | M | 69 | - | |
| Christopher Kurtz | M | 57 | 5 years | |
| Rinko Ghosh | M | 60 | 13 years | |
| Linda A. Adreveno | F | 68 | 5 years | |
| Kevin Brodbeck | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 35 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Samantha Miller
- Personal Network
